Notice2024-02353
National Heart, Lung, and Blood Institute; Notice of Closed Meetings
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
February 6, 2024
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 25 (Tuesday, February 6, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 25 (Tuesday, February 6, 2024)]
[Notices]
[Pages 8223-8224]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-02353]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Heart, Lung, and Blood Institute; Notice of Closed
Meetings
Pursuant to section 1009 of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meetings.
[[Page 8224]]
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Molecular Atlas of Lung Development
(LungMAP) Program.
Date: March 1, 2024.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge I, 6705
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kristen Page, Ph.D., Scientific Review Officer,
Office of Scientific Review/DERA, National Heart, Lung, and Blood
Institute, National Institutes of Health, 6705 Rockledge Drive,
Suite 209-B, Bethesda, MD 20892, (301) 827-7953,
<a href="/cdn-cgi/l/email-protection#0f647d667c7b6a61217f6e686a4f61666721686079"><span class="__cf_email__" data-cfemail="89e2fbe0fafdece7a7f9e8eeecc9e7e0e1a7eee6ff">[email protected]</span></a>.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Early Phase Clinical Trials (R61/R33).
Date: March 1, 2024.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge I, 6705
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Manoj K. Valiyaveettil, Ph.D., Scientific Review
Officer, Blood & Vascular Branch, Office Scientific Review, Division
of Extramural Research Activities (DERA), National Institute of
Health, National Heart, Lung, and Blood Institute, Bethesda, MD
20817, (301) 402-1616, <a href="/cdn-cgi/l/email-protection#432e222d2c296d35222f2a3a2235262637372a2f032d2a2b6d242c35"><span class="__cf_email__" data-cfemail="690408070603471f08050010081f0c0c1d1d000529070001470e061f">[email protected]</span></a>.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; NHLBI TOPMed: Omics Phenotypes of Heart,
Lung, and Blood Disorders (X01).
Date: March 6, 2024.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge I, 6705
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Susan Wohler Sunnarborg, Ph.D., Scientific
Review Officer, Office of Scientific Review/DERA, National, Heart,
Lung, and Blood Institute, National Institutes of Health, 6705
Rockledge Drive, Room 208-Z, Bethesda, MD 20892, (301) 827-7987,
<a href="/cdn-cgi/l/email-protection#8cfff9ffede2a2fff9e2e2edfeeee3feebcce2e5e4a2ebe3fa"><span class="__cf_email__" data-cfemail="1c6f696f7d72326f6972727d6e7e736e7b5c727574327b736a">[email protected]</span></a>.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Molecular Phenotypes of Asthma Exacerbation
in Children.
Date: March 7, 2024.
Time: 1:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge I, 6705
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: YingYing Li-Smerin, M.D., Ph.D., Scientific
Review Officer, Office of Scientific Review/DERA, National Heart,
Lung, and Blood Institute, National Institutes of Health, 6705
Rockledge Drive, Room 207-P, Bethesda, MD 20892-7924, (301) 827-
7942, <a href="/cdn-cgi/l/email-protection#7915100a141c0b1017391711151b1057171011571e160f"><span class="__cf_email__" data-cfemail="315d58425c5443585f715f595d53581f5f58591f565e47">[email protected]</span></a>.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Mentored Career Development Award to Promote
Faculty Research Diversity.
Date: March 8, 2024.
Time: 10:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge I, 6705
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Shelley Sehnert, Ph.D., Scientific Review
Officer, Office of Scientific Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health, 6705 Rockledge
Drive, Suite 208-T, Bethesda, MD 20817, (301) 827-7984,
<a href="/cdn-cgi/l/email-protection#6d1e1e080503081f192d0305010f0443030405430a021b"><span class="__cf_email__" data-cfemail="cbb8b8aea3a5aeb9bf8ba5a3a7a9a2e5a5a2a3e5aca4bd">[email protected]</span></a>.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; The Blood and Marrow Transplant Clinical
Trials Network--Core Clinical Centers (UG1) Review Panel.
Date: March 11, 2024.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge I, 6705
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kazuyo Kegan, Ph.D., Scientific Review Officer,
Office of Scientific Review/DERA, National Heart, Lung, and Blood
Institute, National Institutes of Health, 6705 Rockledge Drive, Room
208-T, Bethesda, MD 20892, (301) 402-1334, <a href="/cdn-cgi/l/email-protection#2c474d565955430247494b4d426c424544024b435a"><span class="__cf_email__" data-cfemail="d0bbb1aaa5a9bffebbb5b7b1be90beb9b8feb7bfa6">[email protected]</span></a>.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; The Blood and Marrow Transplant Clinical
Trials Network Data Coordinating Center (U24) Review Panel.
Date: March 12, 2024.
Time: 11:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge I, 6705
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kazuyo Kegan, Ph.D., Scientific Review Officer,
Office of Scientific Review/DERA, National Heart, Lung, and Blood
Institute, National Institutes of Health, 6705 Rockledge Drive, Room
208-T, Bethesda, MD 20892, (301) 402-1334, <a href="/cdn-cgi/l/email-protection#412a203b34382e6f2a2426202f012f28296f262e37"><span class="__cf_email__" data-cfemail="593238232c203677323c3e383719373031773e362f">[email protected]</span></a>.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Catalyze Product Definition (R61/R33).
Date: March 13, 2024.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge I, 6705
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Manoj K. Valiyaveettil, Ph.D., Scientific Review
Officer, Blood & Vascular Branch, Office Scientific Review, Division
of Extramural Research Activities (DERA), National Institute of
Health, National Heart, Lung, and Blood Institute, Bethesda, MD
20817, (301) 402-1616, <a href="/cdn-cgi/l/email-protection#c1aca0afaeabefb7a0ada8b8a0b7a4a4b5b5a8ad81afa8a9efa6aeb7"><span class="__cf_email__" data-cfemail="1578747b7a7f3b6374797c6c7463707061617c79557b7c7d3b727a63">[email protected]</span></a>.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; Clinical Trials SEP (UG3, U24).
Date: March 14, 2024
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge I, 6705
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Zhihong Shan, Ph.D., M.D., Scientific Review
Officer, Office of Scientific Review/DERA, National Heart, Lung, and
Blood Institute, National Institutes of Health, 6705 Rockledge
Drive, Room 205-J, Bethesda, MD 20892, (301) 827-7085,
<a href="/cdn-cgi/l/email-protection#4e34262726212029603d262f200e20272660292138"><span class="__cf_email__" data-cfemail="8af0e2e3e2e5e4eda4f9e2ebe4cae4e3e2a4ede5fc">[email protected]</span></a>.
Name of Committee: National Heart, Lung, and Blood Institute
Special Emphasis Panel; NHLBI Biorepository: Scientific
Opportunities for Exploratory Research (R21).
Date: March 15, 2024.
Time: 10:00 a.m. to 3:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, Rockledge I, 6705
Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Sun Saret, Ph.D., Scientific Review Officer,
Office of Scientific Review/DERA, National Heart, Lung, and Blood
Institute, National Institutes of Health, 6705 Rockledge Drive, Room
208-S, Bethesda, MD 20892, (301) 435-0270 <a href="/cdn-cgi/l/email-protection#b4c7c1da9ac7d5c6d1c0f4dadddc9ad3dbc2"><span class="__cf_email__" data-cfemail="7d0e0813530e1c0f18093d131415531a120b">[email protected]</span></a>.
(Catalogue of Federal Domestic Assistance Program Nos. 93.233,
National Center for Sleep Disorders Research; 93.837, Heart and
Vascular Diseases Research; 93.838, Lung Diseases Research; 93.839,
Blood Diseases and Resources Research, National Institutes of
Health, HHS)
Dated: February 1, 2024.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-02353 Filed 2-5-24; 8:45 am]
BILLING CODE 4140-01-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>Indexed from Federal Register on February 6, 2024.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.